Profile
BCLI VRTX REGN SGEN ALNY ARGX
Company Name Brainstorm Cell Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $9.29M $116.96B $58.10B $43.15B $41.50B $33.28B
Employees 0.03K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Chaim Lebovits Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
BCLI VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 2
Quant Rating Sell Sell Buy Neutral Strong Sell Sell
Trading
BCLI VRTX REGN SGEN ALNY ARGX
Last Close $1.16 $459.62 $547.36 $228.74 $331.91 $543.48
High 52 $3.25 $516.74 $1201.76 $228.74 $331.91 $671.75
Low 52 $0.22 $396.64 $482.92 $228.74 $224.58 $435.84
Price vs. 52 Week High -64.31 % -11.05 % -54.45 % 0 % 0 % -19.09 %
Price vs. 52 Week Low 427.27 % 15.88 % 13.34 % 0 % 47.79 % 24.7 %
Total Return
BCLI VRTX REGN SGEN ALNY ARGX
1 Month Return 3.11 % 3.56 % 13.34 % 0 % 7.8 % -6.39 %
3 Month Return 0.86 % -3.16 % -4.55 % 0 % 40.79 % -2.1 %
6 Month Return -47.98 % 12.9 % -23.78 % 0 % 41.67 % -12.52 %
9 Month Return -50.21 % 0.95 % -45.96 % 0 % 23.85 % 2.55 %
YTD Return -48.9 % 14.13 % -23.16 % 0 % 41.05 % -11.63 %
1 Year Return 216.85 % -3.15 % -47.08 % 0 % 32.22 % 24.7 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BCLI VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
BCLI VRTX REGN SGEN ALNY ARGX
Asset Growth -56.46 % -0.87 % 36.55 %
Gross Profit Growth 420.38 % 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year 1057.01 % 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth 100 % -93.69 % 128.87 %
Net Income Growth 167.61 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 423.84 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 306.22 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 423.46 % 33.84 % 938.02 %
Operating Income Growth 100 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 55.55 % -113.93 % 80.31 %
Operating 3 Year CFG -135.91 % -118.65 % 88.36 %
Operating 5 Year CFG -233.55 % -131.3 % -135.21 %
Operating 10 Year CFG -421.45 % 12.43 % -64 %
EPS Growth 647.5 % -114.8 % 369.77 %
EPS Diluted Growth 647.5 % -114.97 % 347.67 %
Book Value Per Share -1193.65 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -373.52 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -162.06 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -399.29 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 7.14 % 116.42 % 95.27 %
Free Cash Flow Growth -44308.09 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
BCLI VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -310.45 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM 178.77 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM 167.91 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 90.07 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -432.82 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.21 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.21 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 25.92 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -432.82 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -1.21 -92.97 19.24 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -0.97 -119.36 14.77 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -0.97 -119.36 14.77 -93.1 -914.84 -515.98
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 42.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.8
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.89
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0222
ABSI Absci Corporation 2.77
ABUS Arbutus Biopharma Corporation 3.24
ABVC ABVC BioPharma, Inc. 3.11
ABVX Abivax SA American Depositary Shares 7.96
ACAD ACADIA Pharmaceuticals Inc. 20.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.607
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.18
ACIU AC Immune SA 2.07
ETFs With Exposure to BCLI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 308.03
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00006 136.82
VXF Vanguard Extended Market Index Fund 0.00003 197.5
IWC iShares Micro-Cap ETF 0.00458 133.14
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.8
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.79
STSB iShares Factors US Small Blend Style ETF 0.02 22.13
VTSAX Vanguard Total Stock Market Index Fund 0 150.01
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 149.82
VITSX Vanguard Total Stock Market Index Fund 0 150.04
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000106985 106.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 149.83
AVSC Avantis U.S. Small Cap Equity ETF 0 54.025
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 369.73
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 281.45
Unlock